
Biocon Biologics Signs Global Settlement And License Agreement To Commercialize Biosimilar Aflibercept
New Delhi: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE: 532523, NSE: BIOCON), has announced














